The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml
Research output: Contribution to journal › Journal article › Research › peer-review
In virologically suppressed patients, darunavir-ritonavir (DRV/r) monotherapy could maintain virological suppression similarly to DRV/r and two nucleosides.
| Original language | English |
|---|---|
| Journal | AIDS |
| Volume | 24 |
| Issue number | 2 |
| Pages (from-to) | 223-30 |
| Number of pages | 8 |
| ISSN | 0269-9370 |
| DOIs | |
| Publication status | Published - 16 Jan 2010 |
ID: 34051997